(KVYO) Klaviyo - Overview
Sector: Technology | Industry: Software - Application | Exchange: NYSE (USA) | Market Cap: 4.741m USD | Total Return: -54.1% in 12m
Avg Turnover: 104M
Qual. Beats: 0
Rev. Trend: 99.9%
Qual. Beats: 7
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Klaviyo, Inc. (KVYO) operates a cloud-based Software-as-a-Service (SaaS) platform specializing in business-to-consumer (B2C) customer relationship management (CRM). The company’s core offering unifies marketing, service, and data analytics into a single system, allowing brands to centralize consumer profiles. Key features include AI-driven marketing and customer service agents, automated email and SMS messaging, and predictive data analysis tools designed to optimize consumer engagement across digital channels.
The company utilizes a recurring revenue model typical of the application software sector, where growth is often driven by net revenue retention and the expansion of data-driven automation tools. As a mid-cap player in the competitive CRM landscape, Klaviyo focuses on integrating first-party data to help businesses reduce reliance on third-party advertising cookies. For a deeper look into these financial metrics, consider reviewing the detailed analysis available at ValueRay.
Klaviyo serves a broad client base ranging from individual entrepreneurs and small businesses to large scale enterprises. Headquartered in Boston and incorporated in 2012, the firm has expanded its geographic footprint across the Americas, Europe, the Middle East, and the Asia-Pacific region. Its platform further extends into specialized areas such as product reviews, social interaction data, and centralized customer helpdesks.
- Subscription revenue grows as SMBs adopt AI-driven marketing automation
- Dollar-based net retention rate stabilizes amid enterprise segment expansion
- SMS and push notification adoption drives higher average revenue per user
- Operating margins expand through efficient cloud infrastructure and R&D scaling
| Net Income: -8.64m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.85 > 1.0 |
| NWC/Revenue: 66.72% < 20% (prev 80.85%; Δ -14.14% < -1%) |
| CFO/TA 0.16 > 3% & CFO 237.9m > Net Income -8.64m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (305.8m) vs 12m ago 11.53% < -2% |
| Gross Margin: 74.55% > 18% (prev 75.77%; Δ -1.22% > 0.5%) |
| Asset Turnover: 91.41% > 50% (prev 74.76%; Δ 16.65% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.57 (Total Current Assets 1.15b - Total Current Liabilities 271.0m) / Total Assets 1.52b |
| B: -0.57 (Retained Earnings -867.9m / Total Assets 1.52b) |
| C: -0.03 (EBIT TTM -42.3m / Avg Total Assets 1.44b) |
| D: 3.12 (Book Value of Equity 1.15b / Total Liabilities 370.2m) |
| Altman-Z'' = 4.99 = AAA |
| DSRI: 1.03 (Receivables 72.3m/53.9m, Revenue 1.31b/1.01b) |
| GMI: 1.02 (GM 75.77% / 74.55%) |
| AQI: 0.88 (AQ_t 0.13 / AQ_t-1 0.15) |
| SGI: 1.30 (Revenue 1.31b / 1.01b) |
| TATA: -0.16 (NI -8.64m - CFO 237.9m) / TA 1.52b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of June 07, 2026, the stock is trading at USD 15.58 with a total of 4,763,620 shares traded.
Over the past week, the price has changed by -1.64%,
over one month by -33.22%,
over three months by -26.44% and
over the past year by -54.11%.
Klaviyo has received a consensus analysts rating of 4.39. Therefore, it is recommended to buy KVYO.
- StrongBuy: 14
- Buy: 4
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 29.2 | 87.6% |
P/E Forward = 19.084
P/S = 3.6127
P/B = 4.1099
Revenue TTM = 1.31b USD
EBIT TTM = -42.3m USD
EBITDA TTM = -22.1m USD
Long Term Debt = 93.2m USD (estimated: total debt 117.2m - short term 24.0m)
Short Term Debt = 24.0m USD (from shortTermDebt, last quarter)
Debt = 117.2m USD (from shortLongTermDebtTotal, last quarter) (leases 117.2m already included)
Net Debt = -867.4m USD (calculated: Debt 117.2m - CCE 984.6m)
Enterprise Value = 3.87b USD (4.74b + Debt 117.2m - CCE 984.6m)
Interest Coverage Ratio = unknown (Ebit TTM -42.3m / Interest Expense TTM 0.0)
EV/FCF = 17.32x (Enterprise Value 3.87b / FCF TTM 223.6m)
FCF Yield = 5.77% (FCF TTM 223.6m / Enterprise Value 3.87b)
FCF Margin = 17.04% (FCF TTM 223.6m / Revenue TTM 1.31b)
Net Margin = -0.66% (Net Income TTM -8.64m / Revenue TTM 1.31b)
Gross Margin = 74.55% ((Revenue TTM 1.31b - Cost of Revenue TTM 333.9m) / Revenue TTM)
Gross Margin QoQ = 75.11% (prev 72.17%)
Tobins Q-Ratio = 2.54 (Enterprise Value 3.87b / Total Assets 1.52b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 117.2m)
Taxrate = 15.69% (1.68m / 10.7m)
NOPAT = -35.6m (EBIT -42.3m * (1 - 15.69%)) [loss with tax shield]
Current Ratio = 4.23 (Total Current Assets 1.15b / Total Current Liabilities 271.0m)
Debt / Equity = 0.10 (Debt 117.2m / totalStockholderEquity, last quarter 1.15b)
Debt / EBITDA = 39.23 (negative EBITDA) (Net Debt -867.4m / EBITDA -22.1m)
Debt / FCF = -3.88 (Net Debt -867.4m / FCF TTM 223.6m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.60% (Net Income -8.64m / Total Assets 1.52b)
RoE = -0.75% (Net Income TTM -8.64m / Total Stockholder Equity 1.15b)
RoCE = -3.41% (EBIT -42.3m / Capital Employed (Equity 1.15b + L.T.Debt 93.2m))
RoIC = -2.94% (negative operating profit) (NOPAT -35.6m / Invested Capital 1.21b)
WACC = 10.71% (E(4.74b)/V(4.86b) * Re(10.97%) + D(117.2m)/V(4.86b) * Rd(0.0%) * (1-Tc(0.16)))
Discount Rate = 10.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 7.68%
[DCF] Terminal Value 70.74% ; FCFF base≈187.1m ; Y1≈214.5m ; Y5≈315.7m
[DCF] Fair Price = 29.95 (EV 3.35b - Net Debt -867.4m = Equity 4.22b / Shares 140.9m; r=10.71% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.19 | # QB: 0
Revenue Correlation: 99.91 | Revenue CAGR: 33.80% | SUE: 3.12 | # QB: 7
EPS current Quarter (2026-06-30): EPS=0.19 | Chg30d=-4.80% | Revisions=-74% | Analysts=23
EPS next Quarter (2026-09-30): EPS=0.21 | Chg30d=-0.80% | Revisions=-22% | Analysts=23
EPS current Year (2026-12-31): EPS=0.85 | Chg30d=+2.39% | Revisions=+71% | GrowthEPS=+26.8% | GrowthRev=+23.2%
EPS next Year (2027-12-31): EPS=1.03 | Chg30d=+3.27% | Revisions=+67% | GrowthEPS=+21.8% | GrowthRev=+19.4%
[Analyst] Revisions Ratio: -74%